CompletedN/Aketamine

Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions

Sponsored by University Hospital, Basel, Switzerland

NCT ID
NCT05103319
Target Enrollment
319 participants
Start Date
2021-09-07
Est. Completion
2022-01-30

About This Study

This study is to retrospective investigate the effects of the simultaneous intravenous (i.v.) administration of lidocaine and ketamine on a four to six weeks interval in treatment refractory different chronic pain conditions.

Conditions Studied

Chronic Pain

Interventions

  • •Data collection for statistical analysis to identify patterns of treatment response/ non-response

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* ICD11 Medical diagnosis of chronic pain and its subcategories
* Treatment with intravenous lidocaine and ketamine infusions during the years of 2012 to May 2021 at our pain unit at the USB
* Patient is at least 18 years of age at the beginning of the first infusion treatment

Exclusion Criteria:

* Patient is underage at the beginning of the first infusion treatment
* Documented written refusal of consent for research (general consent or specific study consent)
* Patients undergoing treatment with only lidocaine or ketamine respective

Study Locations (1)

Department of Anesthesiology, University of Basel (USB)
Basel, Switzerland

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions | Huxley